A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors

scientific article published on 01 December 2002

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID12473579

P50authorHans J van der VlietQ57051708
Jos BeijnenQ23771643
Giuseppe GiacconeQ37829946
P2093author name stringRik J Scheper
Yukio Ando
Alfons J M van den Eertwegh
Cornelis J A Punt
Herbert M Pinedo
B Mary E von Blomberg
Heinz Zwierzina
Nobusuke Nishi
Marja Roelvink
Marlies Peters
Rita Ruijter
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectalpha-galactosylceramideQ27105159
P304page(s)3702-3709
P577publication date2002-12-01
P1433published inClinical Cancer ResearchQ332253
P1476titleA phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors
P478volume8